Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siwon Kim

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|January 25, 2022
Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple SclerosisSun Jun Park, Seul Ki Yeon, Yoowon Kim, et al.
Journal of Medicinal Chemistry|October 18, 2021
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal InfectionJi Won Choi, Kyung-Tae Lee, Siwon Kim, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 6, 2021
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's DiseaseMin-Ho Nam, Jong-Hyun Park, Hyo Jung Song, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|January 25, 2022
Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple SclerosisSun Jun Park, Seul Ki Yeon, Yoowon Kim, et al.
Journal of Medicinal Chemistry|October 18, 2021
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal InfectionJi Won Choi, Kyung-Tae Lee, Siwon Kim, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 6, 2021
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's DiseaseMin-Ho Nam, Jong-Hyun Park, Hyo Jung Song, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 4